1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Retinal Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, HM; Huang, JF; Wang, ZJ; Yang, YF; Yao, Y; Zhao, HP | 1 |
| Abran, D; Almazan, G; Beauchamp, MH; Bernier, SG; Brault, S; Chemtob, S; Gobeil, F; Hou, X; Lachapelle, P; Marrache, AM; Peri, KG; Quiniou, C; Roberts, J; Varma, DR | 1 |
| Beauchamp, M; Chemtob, S; Gobeil, F; Hardy, P; Lachapelle, P; Mwaikambo, B; Sennlaub, F; Tremblay, L | 1 |
| Bonhomme, B; Braquet, P; Cluzel, J; Doly, M; Millerin, M | 2 |
| Bonhomme, B; Braquet, P; Doly, M; Droy-Lefaix, MT; Millerin, M | 1 |
| Doly, M; Droy-Lefaix, MT; Jung, H; Munz, K; Remé, C; Wei, Q | 1 |
| Braquet, P; Doly, M; Meyniel, G; Millerin, M | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Retinal Diseases
| Article | Year |
|---|---|
New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy.
Topics: Endothelial Cells; Humans; Ischemia; Lipid Peroxidation; Lipids; Oxidative Stress; Oxygen; Phospholipases A; Platelet Activating Factor; Prostaglandins; Reactive Oxygen Species; Regional Blood Flow; Retina; Retinal Diseases; Retinal Vessels; Signal Transduction; Thromboxane A2 | 2005 |
7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Retinal Diseases
| Article | Year |
|---|---|
Protective effect of high concentration of BN52021 on retinal contusion in cat eyes.
Topics: Animals; Cats; Contusions; Disease Models, Animal; Electroretinography; Eye Injuries; Female; Fibrinolytic Agents; Ginkgolides; Intraocular Pressure; Lactones; Male; Nerve Fibers; Platelet Activating Factor; Retina; Retinal Diseases; Retinal Ganglion Cells; Tomography, Optical Coherence; Tonometry, Ocular | 2015 |
Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.
Topics: Animals; Cell Survival; Endothelium, Vascular; Humans; Hyperoxia; In Vitro Techniques; Injections; Microcirculation; Oxidative Stress; Oxygen; Pericytes; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Retinal Diseases; Retinal Vessels; Swine; Thromboxane A2; Vitreous Body | 2002 |
Protective effect of a specific PAF antagonist on vincristine-induced experimental retinopathy.
Topics: Animals; Azepines; Dark Adaptation; Electroretinography; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Thienopyridines; Triazoles; Vincristine | 1995 |
Prevention of chloroquine-induced electroretinographic damage by a new platelet-activating factor antagonist, BN 50730.
Topics: Animals; Azepines; Chloroquine; Dark Adaptation; Electroretinography; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Tetrazoles; Thienopyridines; Triazoles | 1993 |
Inhibition of vincristine-induced retinal impairments by a specific PAF antagonist.
Topics: Animals; Azepines; Electroretinography; Organ Culture Techniques; Perfusion; Photic Stimulation; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Retinal Diseases; Tetrazoles; Thienopyridines; Triazoles; Vincristine | 1992 |
Light and lithium effects in the rat retina: modification by the PAF antagonist BN 52021.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Diterpenes; Ginkgolides; Image Processing, Computer-Assisted; Lactones; Light; Lithium; Male; Phagosomes; Platelet Activating Factor; Rats; Retina; Retinal Diseases; Rod Cell Outer Segment | 1992 |
[Involvement of PAF (Platelet-Activating Factor) in chloroquine-induced retinopathy].
Topics: Animals; Chloroquine; Electroretinography; Platelet Activating Factor; Rats; Retina; Retinal Diseases | 1992 |